United States

October 3, 2023

Profiles in Diversity Journal Recognizes Two Fujifilm Leaders as “Women Worth Watching”  

Patricia Colombo and Liza Rivera Selected as 2023 Award Winners 

VALHALLA, N.Y., & RESEARCH TRIANGLE PARK, N.C., Oct. 3, 2023 - Fujifilm announced today that Patricia Colombo, chief compliance officer of FUJIFILM Holdings America Corporation and Liza Rivera, vice president of global marketing communications for FUJIFILM Diosynth Biotechnologies, have been named to Profiles in Diversity Journal’s 2023 list of “Women Worth Watching in Leadership.” Now in its 22nd year, the exclusive list recognizes exceptional female leaders across the globe who are influencing their workplaces and industries. 

Ms. Colombo is based in Fujifilm’s Valhalla, N.Y. office, where she oversees compliance for FUJIFILM Holdings America Corporation and its 27 subsidiaries across the U.S., Canada, Colombia and Brazil, spanning a wide range of industries including life sciences, advanced materials, cameras, inkjet solutions, and medical devices, among other core industries. During her 16-year tenure with Fujifilm, Ms. Colombo has focused on innovative new ways to manage the company’s risk profile and inspire employees to work diligently to make a positive impact in their industry and on society. As an accomplished attorney and compliance expert, she has been invited to present at several industry conferences in both the U.S. and Brazil.  

“It’s a great honor to receive this recognition, but it wouldn’t be possible without the support of my team and fellow employees at Fujifilm,” said Patricia Colombo. “Collaboration and innovation are at the core of what we do, and our employees work tirelessly to make a positive impact on society - this award is a great testament to our collective commitment.”  

Ms. Rivera is based in FUJIFILM Diosynth Biotechnologies Research Triangle, N.C., headquarters, and serves as the leading biopharmaceutical contract manufacturing organization’s vice president of global marketing communications. Ms. Rivera first joined Fujifilm as part of the Merck BioManufacturing Network acquisition, where she served as director of commercial development in 2008, was promoted to global marketing director in 2016 and was quickly elevated to vice president of global marketing communications in 2019. She brings a strong depth of marketing, sales and experience in biologics, vaccines and advanced therapies to her position. Passionate about educating the next generation workforce, Ms. Rivera launched a science portal for kids, which currently lives on FUJIFILM Diosynth Biotechnologies website. The portal features a free science game app, designed to help ignite passion for STEM (science, technology, engineering, and mathematics) related fields among the youngest generation.  

“I am incredibly honored to be included in this award and to be amongst some of the most inspiring female leaders making strides for their companies and in their communities,” said Liza Rivera. “Companies that thrive understand that diversity offers the opportunity to tap into numerous viewpoints, assorted problem-solving approaches, and greater innovation. I’m grateful to be a part of an organization that embraces diversity and has enabled me to build a diverse and strong marketing communications team.”  

Established in 1999, Profiles in Diversity Journal is dedicated to promoting and advancing diversity and inclusion in the corporate, government, nonprofit, STEM, and higher education sectors. 

Both Ms. Colombo and Ms. Rivera are featured in the Fall issue of Profiles in Diversity Journal. The online issue may be viewed here. 

About Fujifilm 

FUJIFILM Holdings America Corporation is the regional headquarters for the Americas. It is comprised of 27 affiliate companies across North and Latin America that are engaged in the research, development, manufacture, sale and service of FUJIFILM products and services. The company’s portfolio represents a broad spectrum of industries including medical and life sciences, electronic, chemical, graphic arts, information systems, industrial products, broadcast, recording media, and photography. For more information, please visit: https://www.fujifilm.com/us/en/about/region. 

FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization partner for the development and manufacture of biologics, vaccines and advanced therapies. The company operates a global network with major locations in the United States, the United Kingdom and Denmark and it is building a new manufacturing site in Holly Springs, North Carolina, USA. FUJIFILM Diosynth Biotechnologies has over thirty years of experience in the development and manufacture of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules, viral products and medical countermeasures expressed in a wide array of microbial, mammalian, and host/virus systems. The company offers a comprehensive list of services from cell line development using its proprietary pAVEway™ microbial and Apollo™X cell line systems to process development, analytical development, clinical and FDA-approved commercial manufacturing. Mitsubishi Corporation is a 20% shareholder of FUJIFILM Diosynth Biotechnologies’ UK, Research Triangle Park, North Carolina, Watertown, Massachusetts and College Station, Texas sites. For more information, go to: www.fujifilmdiosynth.com. 

FUJIFILM Holdings Corporation, Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver Value from Innovation in our products and services in the business segments of healthcare, materials, business innovation, and imaging. Our relentless pursuit of innovation is focused on providing social value and enhancing the lives of people worldwide. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information about Fujifilm’s Sustainable Value Plan 2030, click here. For the year ended March 31, 2023, the company had global revenues of approximately 2.9 trillion yen (21 billion $USD at an exchange rate of 134 yen/dollar). For more information, please visit: www.fujifilmholdings.com. 


Marissa Confredo